Consequently, one would expect that genes whose promoters are driven by Stat1 homodimers (or Stat1-Stat3 heterodimers) would be inhibited in their normal regulatory patterns starting from early SLE onset. The gene discussed is STAT3; the disease is systemic lupus erythematosus.